Product DescriptionMirtazapine's primary use is the treatment of moderate to severe clinical depression. There is evidence that mirtazapine can be used to treat generalized anxiety disorder (GAD), social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), panic disorder (PD), post-traumatic stress disorder (PTSD), insomnia, sleep apnea, and pruritus as well, and it may be prescribed off-label for these conditions. Mirtazapine has been reported to be effective in the prophylacticchronic tension headache. Due to its common side effect of increased appetite and weight gain, mirtazapine may also be beneficial to patients who are underweight or are having trouble eating. Because of its antiemetic properties, mirtazapine is reportedly useful in the treatment of nausea and vomiting. Mirtazapine has proven helpful in treating gastroparesis, chemotherapy-induced nausea and vomiting (CINV), vomiting following gastric bypass surgery, and hyperemesis gravidarum treatment of |
Psychedelia
Mirtazapine has mild psychedelic effects which are occasionally encountered by some of its patients. Reports include vivid, bizarre, or even lucid dreams, and auditory and visual hallucinations. These effects tend to be most prominent upon first commencing treatment and usually dissipate with time. They are especially prominent when mirtazapine is taken acutely, taken at high doses, or mixed with cannabis. Because of these properties, mirtazapine has seen a miniscule degree of recreational use, though most of the people that abuse it find the experience unpleasant on account of mirtazapine's lack of relative positive euphoria, strong sedating effects, and tendency to induce restless legs syndrome (RLS) at higher doses.The mechanism of action of these effects is currently unknown, but due to the fact that they seem to be very similar to those of 5-HT2A receptor-mediated serotonergic psychedelics such as LSD and magic mushrooms, it has been suggested that mirtazapine does not function as a true zero intrinsic activity silent antagonist at the 5-HT2A receptor, but is actually a weak partial agonist with low intrinsic activity. This may sufficiently explain the weak nature of the effects, their tendency to fade away with time via tolerance, and mirtazapine's ability to block the effects of other 5-HT2A-mediated psychedelics.
0 comments:
Post a Comment